Devani, A. R., & Prajapati, V. H. (2021). Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Review. Canadian Dermatology Today, 2(s03), 3–8. Retrieved from https://canadiandermatologytoday.com/article/view/2-s03-devani-prajapati